Scandinavian ChemoTech AB (publ) carries out a directed share issue and receives approximately 2.02 MSEK
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE, JAPAN, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH DISCLOSURE, PUBLICATION OR DISTRIBUTION WOULD NOT COMPLY WITH APPLICABLE REGULATIONS OR REQUIRE REGISTRATION OR SIMILAR ACTIONS.Scandinavian ChemoTech AB (publ) (“ChemoTech” or the “Company”) has today, with the support of authorisation from the annual general meeting on 24 May 2022, resolved to carry out a directed